期刊文献+

2704例泌尿系感染者病原菌及耐药性分析 被引量:1

下载PDF
导出
出处 《上海预防医学》 CAS 2006年第4期202-203,共2页 Shanghai Journal of Preventive Medicine
  • 相关文献

参考文献11

  • 1叶应妩,王毓三.全国临床操作规程[M].第3版,南京:东南大学出版社,1997,452-470. 被引量:2
  • 2Fluit AC,Jones ME,Schmitz FJ,et al.Antimicrobial resistance among urinary tract infection[UTI] isolates in Europe; results from the SENTRY antimicrobial surveillance pogram 1997[M].Antonic Van Leeuwenboek,2000,147-152. 被引量:1
  • 3Farreu J,Morrissey I,de Rubeis D,et al.AUK multicentre study of the antimicrobial.susceptibility of bacterial pathogens causing urinary tract infection[J].J Infect,2003,46(2):94-100. 被引量:1
  • 4杨银梅,叶惠芬,陈惠玲.广州地区尿路感染的病原菌分布及其耐药性[J].中国抗感染化疗杂志,2002,2(2):100-103. 被引量:35
  • 5杨念生,武庆庆,陈冬梅,陈雄辉,余学清,叶任高,钟琼.复杂性尿路感染致病菌的耐药性新趋势[J].中华肾脏病杂志,2002,18(3):194-198. 被引量:93
  • 6Szabo D,Barcs I,Rozgonyi F.Extended -speetrum beta-lactamases:an actual problem of hospital microbiology (a review)[J].Acta Microbiol Immunol Hung,1997,44(4):309 -325. 被引量:1
  • 7胡云建,张秀珍.泌尿系统感染病原菌及其耐药现状.见:郑法雷,章友康等主编.肾脏病临床与进展.北京:人民军医出版社,2005:414-421. 被引量:3
  • 8俞树荣.微生物和微生物学检验[M].北京:人民卫生出版社,1999,153. 被引量:2
  • 9National committee for clinical laboratory standards,Performance standards for antimicrobial suscfptibility testing; tenth informational supplement(aerobic dilution).NCCLS,2005,M100 -514. 被引量:1
  • 10Cunba BA.Antibiotic resistance[J].Med clin.North Amer 2000:84(6):1407. 被引量:1

二级参考文献4

共引文献122

同被引文献16

  • 1Coudron PE, Moland ES, Thomson KS. Occurrence anddetection of AmpC beta-lactamases among Escherichiacoli.Klebsiella pneumoniae.and Proteus mirabilis isolatesat a veterans medical center[J]. J Clin Microbiol . 2000,38(5):1791-1796. 被引量:1
  • 2Bush K,Jacoby GA,Medeiros AA. A functional classifica-tion scheme for beta-lactamases and its correlation withmolecular structure [J]. Antimicrob Agents Chemother,1995,39(6):1211-1233. 被引量:1
  • 3Ben-Ami R. A multinational survey of risk factors for in-fection with extended-spectrum beta-lactamase-producingenterobacteriaceae in nonhospitalized patients[J]. Clin In-fect Dis,2009,49(5):682-690. 被引量:1
  • 4Bradford PA. Extended-spectrum beta-lactamases in the21st century : characterization, epidemiology, and detectionof this important resistance threat [J]. Clin MicrobiolRev,2001,14(4) :933-951. 被引量:1
  • 5Clinical and Laboratory Standards Institute. M100-S17.Performance standards for antimicrobial susceptibilitytesting:eighteenth informational supplement[S]. Wayne,PA:CLSI,2008. 被引量:1
  • 6Mukherjee M,Basu S,Mukherjee SK,et al. Multidrug-re-sistance and extended spectrum beta-lactamase productionin uropathogenic E. coli which were isolated from hospi-talized patients in Kolkata, India [J]. J Clin Diagn Res,2013,7(3):449-453. 被引量:1
  • 7Islam MS, Yusuf MA, Islam MB, et al. Frequency of ES-BL in Surgical Site Infection at a Tertiary Care Hospital[J]. J Curr Adv Med Res,2014,1(2) :25-29. 被引量:1
  • 8Yadav KK, Adhikari N,Khadka R,et al. Multidrug resist-ant Enterobacteriaceae and extended spectrum p-lacta-mase producing Escherichia coli;a cross-sectional study inNational Kidney Center,Nepal[J]. Antimicrob Resist In-fect Control,2015 ,4(1) :42. 被引量:1
  • 9Chander A,Shrestha CD. Prevalence of extended spec-trum beta lactamase producing Escherichia coli and Kleb-siella pneumoniae urinary isolates in a tertiary care hospi-tal in Kathmandu,Nepal [J]. BMC Res Notes, 2013 , 6 :487-492. 被引量:1
  • 10Colodner R,Rock W,Chazan B,et al. Risk factors for thedevelopment of extended-spectrum beta-lactamase produ-cing bacteria in nonhospitalized patients [J]. Eur J ClinMicrobiol Infect Dis,2004,23(3) :163-167. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部